Latest | Instant Finance & Market News_第250页

09:54

[ Global X China Robotics And Ai Etf (02807.HK) Rises 1.13% in Morning Trade, Latest Price at HKD 53.800 ] NewTimeSpace News: As of July 27 at 09:52, Global X China Robotics And Ai Etf (02807.HK) rose 1.13%, with a latest price of HKD 53.800.

Tag： Global X China Robotics And Ai Etf ETF 02807.HK

09:48

[ China Merchants CSI Battery Thematic ETF (561910) Rises 1.70%, with Scale Growing by RMB 142 Million Over the Past Week ] NewTimeSpace (newtimespace.com) News,–As of 09:43 on July 27, 2026, China Merchants Battery ETF (561910) rose 1.70%, with its latest price at RMB 0.72.In terms of scale, the ETF’s scale grew by RMB 142 million over the past week, achieving significant growth and ranking 3rd among 11 comparable funds in new scale additions.In terms of units, the ETF’s share count grew by 3.25 billion units over the past year, achieving significant growth and ranking 2nd among 11 comparable funds in new share additions.

Tag： ETF 561910.SH China Merchants CSI Battery Thematic ETF

09:47

[ NASN INTELLIGENT Passes HKEX Listing Hearing; China’s First Commercialised L4 Drive-by-Wire Brake Enterprise ] NewTimeSpace News: NASN Intelligent Tech (Zhejiang) Co., Ltd. passed the Hong Kong Stock Exchange listing hearing on 26 July, with Haitong International and BOCI International acting as joint sponsors. The Company develops intelligent driving motion control technology. It is China’s first enterprise to deploy electric brake booster solutions for the commercial operation of L4 autonomous vehicles. Based on 2025 sales volume, it ranks among China’s top three domestic-owned drive-by-wire brake suppliers and the second-largest independent third-party domestic supplier.

Tag： NASN Intelligent IPO pass the listing hearing

09:42

[ Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF(517520) Rises 2.24% in Morning Trading, with Net Capital Inflows for 4 Consecutive Days Totaling RMB 1.354 Billion ] NewTimeSpace (newtimespace.com) News,–As of 09:37 on July 27, 2026, Yongying Gold Stock ETF (517520) rose 2.24%, with its latest price at RMB 1.83.In terms of scale, the latest asset size of Yongying Gold Stock ETF stood at RMB 11.815 billion, hitting a new 1‑month high and ranking 1st among 6 comparable funds.In terms of units, the latest share count of Yongying Gold Stock ETF reached 6.581 billion units, hitting a new 3‑month high and ranking 1st among 6 comparable funds.

Tag： ETF 517520.SH Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF

09:41

[ PrimeGenX Therapeutics Co., Ltd. Files Second Listing Application with HKEX; CITIC Securities and Minsheng Capital Act as Joint Sponsors ] NewTimeSpace News: PrimeGenX Therapeutics Co., Ltd. submitted its second listing application to HKEX on 24 July, with CITIC Securities and Minsheng Capital serving as joint sponsors. Founded in 2016, it is a biotech firm focused on local delivery targeted therapies for immune inflammatory diseases. Its core asset PG-011 (Pumecitinib), a small-molecule JAK1/2 inhibitor, is being developed in two formulations: pumecitinib gel for mild-to-moderate atopic dermatitis and pumecitinib nasal spray for moderate-to-severe allergic rhinitis. The Company has 63 R&D personnel, accounting for 73.2% of all full-time employees.

Tag： PrimeGenX IPO file a listing application

09:33

[ ZHONGAN INFO TECH Files HKEX Listing Application, Focused on Enterprise AI Intelligent Marketing & Operation Management ] NewTimeSpace News: Zhongan Information Technology (Shenzhen) Co., Ltd. submitted a listing application to HKEX on 24 July, with ICBC International and Guolian Securities International acting as joint sponsors. The Company is an enterprise-focused AI solution provider. Its cumulative client base expanded from 88 at end-2023 to 361 at end-2025, representing a compound annual growth rate of 102.5%, and further rose to 409 as at 31 May 2026.

Tag： ZHONGAN INFO TECH IPO file a listing application

09:24

[ CATL(03750.HK)2026 Interim Report - Profit Attributable to Shareholders stood at CNY 43.28 billion, YoY increase of 41.98% ] NewTimeSpace (newtimespace.com) News, July 26, 2026, CATL(03750.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 276.92 billion, increased by 54.8% YoY

Tag： CATL 03750.HK NewTimeSpace

09:22

[ Novaken Pharm Files Second HKEX Listing Application; China’s First Dissolvable Microneedle Patch Under Clinical Development ] NewTimeSpace News: Guangzhou Novaken Pharm Co., Ltd. submitted its second listing application to the Hong Kong Stock Exchange on 24 July, with Guotai Junan International acting as the sole sponsor. Founded in 2007, it is a clinical-stage pharmaceutical enterprise focusing on the development and commercialisation of improved new drugs. Its core product DHMP (Dexmedetomidine Hydrochloride Microneedle Patch) is China’s first dissolvable microneedle pharmaceutical patch approved for clinical trials and the only candidate progressing into Phase II clinical studies to date. Another core asset XJN010 is the first investigational product targeting off episodes of Parkinson’s Disease to secure clinical trial approval in China.

Tag： NOVAKEN PHARM IPO file a listing application

08:46

[ JIANGXI BIOLOGY(06915.HK): Veterinary Tetanus Antitoxin Production Line Officially Put into Operation ] NewTimeSpace News: JIANGXI BIOLOGYannounced on 27 July that the veterinary tetanus antitoxin production line of its wholly-owned subsidiary Chifeng Boen Pharmaceutical Co., Ltd. was officially commissioned in Chifeng, Inner Mongolia on 20 July 2026.

Tag： Jiangxi Biology 06915.HK

08:43

[ Anker Innovations (00668.HK): H-shares Included in Stock Connect Eligible Securities List ] NewTimeSpace News: Anker Innovations announced on 27 July that the Company’s H-shares listed on the Hong Kong Stock Exchange have been included in the eligible securities lists of both Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect with effect from the same date.

Tag： Anker Innovations 00668.HK

07:53

[ IMPACT Therapeutics(07630.HK): IMP3201 Nominated as Preclinical Candidate Compound, a Dual-Loaded ADC Targeting CEACAM5 ] NewTimeSpace News: IMPACT Therapeuticsdisclosed in an announcement dated July 27 that the Company has nominated IMP3201 as its Preclinical Candidate Compound (PCC), a first-in-class dual-loaded ADC targeting CEACAM5 derived from the Company’s proprietary dual-loaded ADC platform.

Tag： IMPACT Therapeutics 07630.HK

07:47

[ JIANGXI BIOLOGY(06915.HK): Stabilisation Period Concludes, Over-Allotment Option Lapses ] NewTimeSpace News: JIANGXI BIOLOGYannounced on 26 July that the stabilisation period for its global offering ended on 25 July 2026, and the over-allotment option was not exercised and has lapsed.

Tag： Jiangxi Biology 06915.HK

07:42

[ UBTECH Robotics (09880.HK): Purchase of Shares from the Market Pursuant to H-share Incentive Scheme ] NewTimeSpace News: UBTECH Robotics announced on 26 July that pursuant to its H-share incentive scheme, the trustee purchased 125,000 H-shares from the market on 24 July 2026 at a total consideration of approximately HK$9.7427 million.

Tag： Ubtech Robotics 09880.HK

07:38

[ Akeso(09926.HK): Grant of Share Options and Restricted Share Units ] NewTimeSpace News: Akeso announced on July 26 that the Company granted 3,603,500 share options to 167 grantees at an exercise price of HK$99.50 per share. Meanwhile, 1,648,500 restricted share units with nil purchase price were awarded to 162 grantees.

Tag： AKESO 09926.HK

07:32

[ Home Control (01747.HK): Signs Strategic Cooperation MOU with Articura on Indonesia Localized Healthcare AI ] NewTimeSpace News: Home Control announced on July 27 that its wholly-owned subsidiary Orbiva has entered into a Memorandum of Understanding (MOU) for strategic cooperation with Articura, an Indonesian healthcare AI firm. The two parties intend to explore cooperation on healthcare AI infrastructure and digital health solutions that comply with local Indonesian regulatory requirements.

Tag： HOME CONTROL 01747.HK

07:27

[ Jacobio Pharmaceuticals(01167.HK): First Patient Dosed in Phase IIa Clinical Trial of BET Inhibitor JAB-8263 for Rheumatoid Arthritis ] NewTimeSpace News: Jacobio Pharmaceuticals announced on July 27 that the Phase IIa clinical trial of its self-developed BET inhibitor JAB-8263 for rheumatoid arthritis has completed the first patient dosing in China.

Tag： Jacobio Pharmaceuticals 01167.HK

19:04

[ China International Development (00264.HK): JV Company's Subsidiary Enters Pre-Fabricated AIDC Module Procurement Contract; Fee Approximately US$24.98 Million ] NewTimeSpace News: China International Development (0264.HK) announced on July 26 that Ganic Synergy, a direct wholly-owned subsidiary of its non-wholly owned JV Company, entered into a procurement contract with independent third party Brightray Veridian on July 26 to provide pre-fabricated AI data center (AIDC) module procurement services, including procurement, transportation, acceptance testing, and site installation, at a fee of approximately US$24.98 million (approximately HK$195.96 million). The Pre-Fabricated AIDC Modules will be delivered to the Customer's AIDC project site in Johor Bahru, Malaysia. This contract will help the JV Company accumulate operational experience in the AI infrastructure sector, and the JV Company is in close consultation with the Customer regarding remaining orders for the project.

Tag： 00264.HK AI

19:01

[ Laifual Drive (03952.HK): Partially Exercises Over-Allotment Option for 736,400 H Shares; Stabilization Period Ends ] NewTimeSpace News: Laifual Drive (3952.HK) announced on July 25 that its sponsor and overall coordinator partially exercised the over-allotment option on July 25, involving 736,400 H shares representing approximately 5.48% of the total offer shares initially available before exercise, to be issued at HK$85.50 per share with expected listing on July 27, and the company will receive additional net proceeds of approximately HK$59.8 million. The global offering stabilization period ended on the same day, during which the stabilization manager over-allocated 2,016,200 shares and purchased 1,279,800 shares in the market; the unexercised portion of the over-allotment option has lapsed.

Tag： Laifual Drive 03952.HK

18:59

[ Want Want China (00151.HK): Issues Profit Warning; Q1 Revenue Down ~6%, Shareholders' Profit Down ~38% ] NewTimeSpace News: Want Want China (0151.HK) issued a profit warning on July 26, expecting revenue for the three months ended June 30, 2026 to decrease by approximately 6% year-on-year and profit attributable to equity holders to decrease by approximately 38%, mainly due to weakening market sentiment and rising operating expenses. The traditional wholesale channel, accounting for over half of total revenue, saw double-digit revenue decline, while operating expenses rose by high single digits. If trends continue, interim results for the six months ended September 30, 2026 are expected to be negatively affected. The Group will respond by optimizing product-channel mix, launching higher-margin new products, and refining distributor incentive policies.

Tag： WANT WANT CHINA 00151.HK

18:57

[ Xunce (03317.HK): Signs Strategic Cooperation Agreement with Shenzhen Kaihong to Explore Token Factory System Integrated with Smart Terminal OS ] NewTimeSpace News: Xunce Technology (3317.HK) announced on July 26 that it has formally signed a strategic cooperation agreement with Shenzhen Kaihong, under which both parties will jointly explore a Token factory system integrated with smart terminal operating systems, jointly build an integrated AI data infrastructure of "underlying operating system - full-chain data governance - vertical small models", land vertical industry small models in energy, water, agriculture, smart city, and other sectors, and jointly build a Token factory business model and ecosystem. The agreement signed is a strategic cooperation agreement, and specific business cooperation models will be separately negotiated and formal business contracts will be signed.

Tag： XUNCE 03317.HK